Faster market access for generics in US
October 29, 2003Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut …
AstraZeneca rises on Crestor hopes
October 29, 2003AstraZeneca made significant stock market gains following indications its new superstatin Crestor will receive a positive review from US regulatory …
Elan sues King Pharma over drug sales
October 29, 2003Elan, King Pharmaceuticals
Elan is taking legal action to force King Pharmaceuticals to buy two drugs it urgently needs to divest to help …
GSK gives way on Paxil patents
October 29, 2003New measures by the FDA to speed up patient access to generic medicines have claimed their first scalp after GlaxoSmithKline …
BMA elects new leader
October 29, 2003A consultant surgeon at Halton Hospital in Cheshire has been elected as new Chairman of the BMA to replace Dr …
MHRA must engage more with public, say MPs
October 29, 2003The MHRA has come under criticism from MPs over its efforts to communicate with the public and lead improvements in …
Schering-Plough plays down Zetia label change
October 29, 2003Schering-Plough has changed the labelling of its new cholesterol absorbing drug Zetia after some patients reported experiencing hypersensitivity reactions, including …
Pharma executive proves controversial choice for AIDS leader
October 29, 2003President George Bush has appointed Randy Tobias, former chief executive of Eli Lilly, to lead US efforts to combat AIDS …
US Senate backing for Canadian imports
October 29, 2003The US Senate has backed a limited scheme to allow the parallel importation of drugs from Canada in order to …
First new HIV drug in seven years gets approval
October 29, 2003The first novel HIV treatment in seven years, Roche Fuzeon, is to undergo fast track approval in the US.Fuzeon was …
New ministerial team unveiled at Department of Health
October 29, 2003The Government has used the unexpected departure of Alan Milburn to bring in four new ministers to head the Department …
Doctors shutting out sales reps
October 29, 2003Doctors are making a conscious decision to give up less of their time to see sales reps, according to a …
NHS targets to flourish under ‘arch moderniser
October 29, 2003New Health Secretary Dr John Reid has committed the NHS to continued reform despite a growing chorus of disapproval over …
AZ settles $355m fraud case
October 29, 2003AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total …
Latest content
